跳至主要内容
临床试验/EUCTR2013-001295-38-AT
EUCTR2013-001295-38-AT进行中(未招募)不适用

An open, single-centre, non-controlled study of efficacy, safety and usability of the GlucoTab system for glycaemic management in non-critically ill patients with type 2 diabetes at general wards

Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klin. Abt. für Endokrinologie und Stoffwechsel0 个研究点开始时间: 2013年3月28日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • •- Informed consent obtained after being advised of the nature of the study
  • •- Male or female aged =18 years
  • •- Type 2 diabetes (treated with diet, oral agents, non-insulin injected anti-diabetic medicine, insulin therapy or any combination of the four) or newly diagnosed hyperglycaemia which requires s.c. insulin therapy
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1.2 Adults (18-64 years) yes
  • •F.1.2.1 Number of subjects for this age range 50
  • •F.1.3 Elderly (>=65 years) yes
  • •F.1.3.1 Number of subjects for this age range 50

排除标准

  • •- Type 1 diabetes, gestational diabetes
  • •- Any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient
  • •- Pregnancy
  • •- Any mental condition rendering the patient incapable of giving his consent
  • •- Known or suspected allergy to insulin glargine or insulin aspart
  • •- Continuous parenteral nutrition
  • •- Participation in another trial which can influence the software algorithm

研究者

发起方
Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klin. Abt. für Endokrinologie und Stoffwechsel

相似试验